Antiviral trial for treating long covid symptoms
Part of Infections, Lungs & breathing clinical trials.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with long COVID by a doctor and have had symptoms for at least 6 months
- You currently have at least moderate fatigue and post-exertional malaise (feeling worse after activity)
- You are not taking certain medications or have certain health conditions that might interfere with the study drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of antiviral medications can help reduce Long COVID symptoms by targeting viruses that may stay in the body. If you have Long COVID, this treatment might help you feel better.
This trial tests whether a combination of two existing drugs, maraviroc and atorvastatin, can help reduce long covid symptoms like fatigue, brain fog, and shortness of breath. It aims to improve daily functioning for people who have had symptoms for more than six months.
This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.